Patent · US Active

High-purity quinoline derivative and method for manufacturing same

US10822307B2 · kind B2 · utility

9Cited by
98References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 3, 2019
Grant dateNov 3, 2020
Priority date
Expiry dateSep 3, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/47
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a compound represented by formula (IV) or a salt thereof, wherein the content of the compound represented by formula (I) is 350 ppm by mass or less.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.